NMRA•benzinga•
Stifel Downgrades Neumora Therapeutics to Hold, Lowers Price Target to $2
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 7, 2025 by benzinga